2.Research advances in the pathogenesis, diagnosis and treatment of hemophagocytic lymphohistiocytosis in children.
Journal of Experimental Hematology 2014;22(4):1162-1166
Hemophagocytic lymphohistiocytosis (HLH), or hemophagocytic syndrome (HPS), is characterized clinically by abrupt onset and progressive deterioration and even death. HLH is much more prevalent in children, and is potentially fatal if early diagnosis is not made and appropriate HLH-directed therapy not instituted. Increasing genetic defects and underlying diseases or causative factors have been identified to be closely implicated in the pathogenesis of HLH. In addition, great advances have been made in the past few years in terms of HLH diagnosis and clinical management. In the present review, the cause of disease, contemporary classification, epidemiology, genetic defects and molecular mechanisms, updated diagnostic criteria and novel treatment strategies for childhood HLH are summarized.
Child
;
Humans
;
Lymphohistiocytosis, Hemophagocytic
;
diagnosis
;
pathology
;
therapy
4.Research advances in molecular genetics and treatment of familial hemophagocytic lymphohistiocytosis.
Chinese Journal of Contemporary Pediatrics 2013;15(11):965-969
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome characterized by pancytopenia and multiple organ infiltrations of lymphocytes and histiocytes with proliferation and hemohpagocytic activity. HLH is classified as primary (or familial) and secondary. Familial HLH is common in infants and young children, and is related to genetic defects. This article aims to review research advances on PRF1, UNC13D, STX11 and STXBP2, as well as the other 5 genes associated with familial HLH based on molecular genetics, and to summarize diagnosis and treatment methods for this disease.
Humans
;
Lymphohistiocytosis, Hemophagocytic
;
diagnosis
;
etiology
;
genetics
;
therapy
;
Molecular Biology
7.Research Advance of the Mechanisms, Clinical Characteristics and Treatment Strategy of Coagulation Dysfunction in Hemophagocytic Lymphohistiocytosis --Review.
Jing KANG ; Shi-Xuan WANG ; Fei LI
Journal of Experimental Hematology 2022;30(3):959-964
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease caused by uncontrolled proliferation of activated macrophage, and secreting high amounts of inflammatory cytokines which lead to multi-organ dysfunction syndrome. HLH patients often show different clinical characteristics during the disease was progressed, in which coagulopathy were the most common, including thrombocytopenia and hypofibrinogenemia, those are the major cause of death in patients, and the clinicians should increase awareness of the mechanisms, clinical characteristics, prognosis and treatment. In this review, the above problems are briefly summarized, to deepen understanding of the HLH related coagulation dysfunctions, and early identification and treatment to reduce mortality, so as to provide more opportunities for HLH patients to recieve subsequent treatment.
Afibrinogenemia
;
Blood Coagulation Disorders/therapy*
;
Humans
;
Lymphohistiocytosis, Hemophagocytic/therapy*
;
Prognosis
;
Thrombocytopenia
8.Hemophagocytic lymphohistiocytosis manifesting as sepsis in children: a report of 6 cases.
Xiao-Sheng HAO ; Cui-Ying WANG ; Yin-Bo CHEN
Chinese Journal of Contemporary Pediatrics 2015;17(12):1360-1362
Child
;
Child, Preschool
;
Female
;
Humans
;
Infant
;
Lymphohistiocytosis, Hemophagocytic
;
complications
;
immunology
;
Male
;
Sepsis
;
etiology
;
therapy
10.Research advance on hemophagocytic lymphohistiocytosis.
Yu NIU ; Ai-Li HE ; Wang-Gang ZHANG
Journal of Experimental Hematology 2010;18(1):262-267
Hemophagocytic lymphohistiocytosis (HLH) is named as hemophagocytic syndrome (HPS) and is a complicated disease with reactive hyperplasia of mononuclear/macrophagocytic system. This disease characterised by release of massive cytokines and severe functional destruction of visceral organs, which results from immune function disturbance causing by various pathogenic factors. The cardinal clinical symptoms of HLH are prolonged fever, hepatosplenomegaly, cytopenia, elevated ferritin and triglycerides, low fibrinogen, symptom in nerve system and so on. Nevertheless, impaired function of natural killer cells and cytotoxic T-cell is characteristic for HLH. HLH has of two different types that may be difficult to distinguish from one another: a primary and a secondary form. The combined immunochemotherapy of dexamethasone, etoposide and cyclosporin A and hematopoietic stem cell transplantation are considered as the effective therapies for HLH. In this article, the recent advance in research on the etiological factors, pathogenesis, clinical manifestations, laboratory examination, diagnosis as well as recommended therapy of HLH were reviewed.
Humans
;
Lymphohistiocytosis, Hemophagocytic
;
diagnosis
;
etiology
;
immunology
;
pathology
;
therapy
;
Mononuclear Phagocyte System